[go: up one dir, main page]

AU2001232345A1 - Compositions for preventing and treating digestive diseases - Google Patents

Compositions for preventing and treating digestive diseases

Info

Publication number
AU2001232345A1
AU2001232345A1 AU2001232345A AU2001232345A AU2001232345A1 AU 2001232345 A1 AU2001232345 A1 AU 2001232345A1 AU 2001232345 A AU2001232345 A AU 2001232345A AU 2001232345 A AU2001232345 A AU 2001232345A AU 2001232345 A1 AU2001232345 A1 AU 2001232345A1
Authority
AU
Australia
Prior art keywords
compositions
preventing
digestive diseases
treating digestive
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001232345A
Other versions
AU2001232345B2 (en
Inventor
Hiromasa Araki
Kazuaki Kakehi
Atsufumi Kawabata
Kenzo Kawai
Ryotaro Kuroda
Hiroyuki Nishikawa
Sachiyo Nishimura
Shuichi Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Original Assignee
Fuso Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000047515A external-priority patent/JP4065642B2/en
Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd
Publication of AU2001232345A1 publication Critical patent/AU2001232345A1/en
Application granted granted Critical
Publication of AU2001232345B2 publication Critical patent/AU2001232345B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001232345A 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases Ceased AU2001232345B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000047515A JP4065642B2 (en) 2000-02-24 2000-02-24 Composition for prevention and treatment of digestive system diseases
JP2000-47515 2000-02-24
PCT/JP2001/001188 WO2001062291A1 (en) 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases

Publications (2)

Publication Number Publication Date
AU2001232345A1 true AU2001232345A1 (en) 2001-11-15
AU2001232345B2 AU2001232345B2 (en) 2004-09-23

Family

ID=18569755

Family Applications (2)

Application Number Title Priority Date Filing Date
AU3234501A Pending AU3234501A (en) 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases
AU2001232345A Ceased AU2001232345B2 (en) 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU3234501A Pending AU3234501A (en) 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases

Country Status (8)

Country Link
US (2) US20030166553A1 (en)
EP (1) EP1258251B1 (en)
JP (1) JP4065642B2 (en)
AT (1) ATE428444T1 (en)
AU (2) AU3234501A (en)
CA (1) CA2400650C (en)
DE (1) DE60138366D1 (en)
WO (1) WO2001062291A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
GB0213286D0 (en) * 2002-06-10 2002-07-24 Univ Edinburgh Par-2-Activating peptide derivative and pharmaceutical composition using the same
EP1667681A4 (en) 2003-10-03 2009-09-30 Astron Res Pvt Ltd A novel transmucosal delivery system
JP4653516B2 (en) * 2004-02-27 2011-03-16 扶桑薬品工業株式会社 Tear secretion promoting peptide and composition thereof
JP2008510726A (en) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド Compositions and methods comprising proteinase activated receptor antagonists
JPWO2006035937A1 (en) 2004-09-30 2008-05-15 興和株式会社 Method for producing (1,3-disubstituted indolyl) urea derivatives, production intermediates thereof, and production methods thereof
EP1845104A4 (en) 2004-12-28 2009-08-05 Kowa Co AGONIST OF THE RECEIVER PAR-2
JP4842254B2 (en) 2005-03-29 2011-12-21 興和株式会社 PAR-2 agonist
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766569A (en) * 1985-03-04 1988-08-23 Lattice Semiconductor Corporation Programmable logic array
US5541116A (en) * 1991-09-30 1996-07-30 B.R.A.H.M.S. Diagnostica Gmbh Method for the stabilization of endogenous, physiologically active peptides
US5517627A (en) * 1992-09-18 1996-05-14 3Com Corporation Read and write data aligner and method
US5619665A (en) * 1995-04-13 1997-04-08 Intrnational Business Machines Corporation Method and apparatus for the transparent emulation of an existing instruction-set architecture by an arbitrary underlying instruction-set architecture
US5636224A (en) * 1995-04-28 1997-06-03 Motorola Inc. Method and apparatus for interleave/de-interleave addressing in data communication circuits
JPH11171791A (en) * 1997-10-07 1999-06-29 Kanegafuchi Chem Ind Co Ltd Microbial removing agent and/or germicide for bacterium of genus helicobacter containing proteolytic enzyme and therapeutic agent and/or onset suppressant for disease caused by the same bacterium
US6963962B2 (en) * 2002-04-11 2005-11-08 Analog Devices, Inc. Memory system for supporting multiple parallel accesses at very high frequencies

Similar Documents

Publication Publication Date Title
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AUPR105400A0 (en) Processes and compositions for water treatment
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2002219472A1 (en) Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
AU2495200A (en) Compositions and methods for the treatment of tumor
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
AU2002318935A1 (en) Methods and compositions for treating and preventing distal bowel lesions
AU6157700A (en) Malodour treatment compositions
AU2001245987A1 (en) Compositions and methods for gene therapy
AU7360700A (en) Methods and compositions for preventing and treating urinary tract disorders
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2001274877A1 (en) Pest treatment composition
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU3434601A (en) Compositions and methods for the treatment of immune related diseases